CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company
FENNEC PHARMACEUTICALS INC.
Sign in to watch- Ticker
- FENC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (919) 636-4530
- Business address
- PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Former names
- ADHEREX TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,310,718
- in 4 filings, $1.2M under 10b5-1 plans
Net −$1,310,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-15 | Brughera Marco Maria Director | Sale 10b5-1 | −15,545 | $10.29 | $160K | 0 |
| 2026-09-01 | Raykov Rosty Former Director | Sale 10b5-1 | −10,000 | $12.11 | $121K | 124,411 |
| 2026-08-31 | Sayad Pierre Sargis Chief Medical Officer | Sale | −12,000 | $12.18 | $146K | 9,519 |
| 2026-08-27 | Andrade Robert CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −75,000 | $11.78 | $884K | 217,675 |
| 2026-08-03 | Raykov Rosty Former Director | Sale 10b5-1 | −10,000 | $9.58 | $96K | 131,633 |
| 2026-07-01 | Raykov Rosty Former Director | Sale 10b5-1 | −9,599 | $10.41 | $100K | 138,855 |
| 2026-06-01 | Raykov Rosty Director | Sale 10b5-1 | −9,747 | $9.62 | $94K | 130,079 |
| 2026-05-11 | RALLIS CHRIS A Director | Sale 10b5-1 | −8,346 | $7.04 | $59K | 63,077 |
| 2026-05-01 | Raykov Rosty Director | Sale 10b5-1 | −10,781 | $6.47 | $70K | 121,451 |
| 2026-04-01 | Raykov Rosty Director | Sale 10b5-1 | −10,946 | $6.31 | $69K | 113,856 |
| 2026-03-02 | Raykov Rosty Director | Sale 10b5-1 | −10,079 | $8.36 | $84K | 103,996 |
| 2026-02-02 | Raykov Rosty Director | Sale 10b5-1 | −10,349 | $7.76 | $80K | 98,477 |
| 2026-01-02 | Raykov Rosty Director | Sale 10b5-1 | −10,312 | $7.60 | $78K | 88,020 |
| 2025-12-24 | Southpoint Capital Advisors LP 10% owner | Sale | −1,000,000 | $7.50 | $7.5M | 2,744,741 |
| 2025-12-05 | Raykov Rosty Director | Sale 10b5-1 | −10,000 | $7.54 | $75K | 77,526 |
| 2025-11-18 | Southpoint Capital Advisors LP 10% owner | Sale | −19,341 | $8.79 | $170K | 3,744,741 |
| 2025-11-17 | Southpoint Capital Advisors LP 10% owner | Sale | −85,918 | $8.79 | $755K | 3,764,082 |
| 2025-11-14 | Southpoint Capital Advisors LP 10% owner | Sale | −160,100 | $8.00 | $1.3M | 3,850,000 |
| 2025-11-05 | Raykov Rosty Director | Sale 10b5-1 | −10,000 | $8.10 | $81K | 82,318 |
| 2025-10-10 | RALLIS CHRIS A Director | Sale 10b5-1 | −1,775 | $9.24 | $16K | 57,079 |
Page 1 of 2 · 29 trades